Alexion gets a Breakthrough designation for ALXN1101

|About: Alexion Pharmaceuticals, Inc. (ALXN)|By:, SA News Editor

Alexion Pharma (ALXN) gets a Breakthrough Therapy designation for cyclic pyranopterin monophosphate for the treatment of MoCD. (PR)